Brief: Synact Pharma Appoints Jeppe Øvlesen As CEO
March 20 (Reuters) - SynAct Pharma AB SYNACT.ST :
* SYNACT PHARMA APPOINTS JEPPE ØVLESEN CEO
* JEPPE ØVLESEN WAS APPOINTED AS NEW CEO SUCCEEDING TORBJØRN
BJERKE EFFECTIVE IMMEDIATELY DUE TO A DISAGREEMENT OVER STRATEGY
* FROM 2015 TO 2023 ØVLESEN WAS CEO OF SYNACT PHARMA
Source text for Eikon: ID:nMFN4BH20W
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development